References

Unmet Needs in Hemophilic Arthropathy

10.1016/j.blre.2025.101304 · 2025 · External reference

Joint Health and Pain in the Changing Hemophilia Treatment Landscape

10.1080/17474086.2024.2378936 · 2024 · External reference

Contemporary Approaches to Treat People With Hemophilia: What's New and What's Not?

10.1016/j.rpth.2025.102696 · 2025 · External reference

10.3324/haematol.2026.301186

10.3324/haematol.2026.301186 · External reference

The Biology of Incretin Hormones

10.1016/j.cmet.2006.01.004 · 2006 · External reference

GLP‐1‐based Therapies for Diabetes, Obesity and Beyond

10.1038/s41573-025-01183-8 · 2025 · External reference

The Expanding Landscape of GLP‐1 Medicines

10.1038/s41591-025-04124-5 · 2026 · External reference

Antiinflammatory Actions of Glucagon‐Like Peptide‐1‐based Therapies Beyond Metabolic Benefits

10.1172/jci194751 · 2025 · External reference

Diagnosis and Treatment of Chronic Synovitis in Patients With Haemophilia: Consensus Statements From the Italian Association of Haemophilia Centres

10.1111/bjh.17919 · 2022 · External reference

Hemophilic Arthropathy: How to Diagnose Subclinical Bleeding Early and How to Orthopedically Treat a Damaged Joint

10.1080/17474086.2023.2232547 · 2023 · External reference

Cartilage Degeneration in Hemophilic Arthropathy: To Focus on Prevention or Regeneration?

10.1080/17474086.2025.2545339 · 2025 · External reference

Haemophilic Arthropathy: A Narrative Review on the Use of Intra‐Articular Drugs for Arthritis

10.1111/hae.13857 · 2019 · External reference

Platelet‐Rich Plasma versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

10.1177/0363546520909397 · 2021 · External reference

Effects of Injections of Monocytes, Platelet‐Rich Plasma, and Hyaluronic Acid in Adults With Knee Osteoarthritis: An Observational Study

10.3390/jfmk10020104 · 2025 · External reference

Roles of Glucagon‐Like Peptide 1 Receptor Agonists in Immune Cell Biology and Autoimmune/Autoinflammatory Diseases

10.1186/s13578-025-01486-8 · 2025 · External reference

Glucagon‐Like Peptide‐1 Receptor Regulates Macrophage Migration in Monosodium Urate‐Induced Peritoneal Inflammation

10.3389/fimmu.2022.772446 · 2022 · External reference

Exenatide Ameliorates Inflammatory Response in Human Rheumatoid Arthritis Fibroblast‐Like Synoviocytes

10.1002/iub.2031 · 2019 · External reference

Glucagon‐Like Peptide and Its Receptor Agonists for the Treatment of Rheumatic Diseases

10.5493/wjem.v15.i3.107020 · 2025 · External reference

The Protective Effects of lixisenatide Against Inflammatory Response in Human Rheumatoid Arthritis Fibroblast‐Like Synoviocytes

10.1016/j.intimp.2019.105732 · 2019 · External reference

Liraglutide, a Glucagon‐Like Peptide 1 Receptor Agonist, Exerts Analgesic, Anti‐Inflammatory and Anti‐Degradative Actions in Osteoarthritis

10.1038/s41598-022-05323-7 · 2022 · External reference

Glucagon‐Like Peptide‐1 Receptor Regulates Endoplasmic Reticulum Stress‐Induced Apoptosis and the Associated Inflammatory Response in Chondrocytes and the Progression of Osteoarthritis in Rat

10.1038/s41419-017-0217-y · 2018 · External reference

The Protective Effects of Dulaglutide Against Advanced Glycation End Products (AGEs)‐Induced Degradation of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes

10.1016/j.cbi.2020.108968 · 2020 · External reference

Semaglutide Ameliorates Osteoarthritis Progression Through a Weight Loss‐Independent Metabolic Restoration Mechanism

10.1016/j.cmet.2026.01.008 · 2026 · External reference

Emerging Therapeutic Potential of Glucagon‐Like Peptide‐1 Receptor Agonists in Knee Osteoarthritis: A Systematic Review

10.3389/fphar.2025.1627691 · 2025 · External reference

Effect of Glucagon‐Like Peptide‐1 Receptor Agonists in Osteoarthritis: A Systematic Review of Pre‐Clinical and Human Studies

10.1016/j.ocarto.2025.100567 · 2025 · External reference

Detection of GLP‐1 and DPP‐4 in Synovial Fluid: Implications for Therapeutical Strategies in Arthritis

10.1016/s2665-9913(26)00074-3 · 2026 · External reference

Beyond Weight Loss: GLP‐1 Emerges as a Disease‐Modifying Signal in Osteoarthritis

10.1016/j.joca.2025.06.011 · 2025 · External reference

Defective Lymphangiogenesis and Iron Removal After Hemarthrosis in FVIII‐Deficient Mice Are Rectified With Therapeutic FVIII Administration—Implications for Joint Health

10.1016/j.jtha.2025.08.016 · 2025 · External reference

Vascular Remodeling Underlies Rebleeding in Hemophilic Arthropathy

10.1002/ajh.24133 · 2015 · External reference

Exendin‐4 Inhibits Endothelial Protein C Receptor Shedding in Vitro and in Vivo

10.1016/j.phrs.2014.04.005 · 2014 · External reference

Neuroinflammatory Markers in Patients With Haemophilia and Healthy Controls: Where Are the Differences?

10.1111/hae.14881 · 2023 · External reference

GLP‐1 Agonists: A Game Changer in Pain Treatment and Addiction

10.1080/17581869.2025.2536998 · 2025 · External reference

Managing Older Patients With Hemophilia

10.1182/asheducation-2015.1.41 · 2015 · External reference

Reducing the Risk of Atherosclerotic Cardiovascular Disease in People With Hemophilia: The Importance of Primary Prevention

10.1016/j.jtha.2024.01.017 · 2024 · External reference

Obesity and the Risk of Cardiometabolic Diseases

10.1038/s41569-023-00847-5 · 2023 · External reference

Glucagon‐Like Peptide 1 Receptor Agonists in Patients with Inflammatory Arthritis or Psoriasis: A Scoping Review

2024 · External reference

The Expanding Benefits of GLP‐1 Medicines

10.1016/j.xcrm.2025.102214 · 2025 · External reference

Blood‐Induced Joint Disease: The Pathophysiology of Hemophilic Arthropathy

10.1111/j.1538-7836.2010.03962.x · 2010 · External reference

Hemophilic Arthropathy: Current Knowledge and Future Perspectives

10.1111/jth.15444 · 2021 · External reference

TAFI Deficiency Causes Maladaptive Vascular Remodeling After Hemophilic Joint Bleeding

10.1172/jci.insight.128379 · 2019 · External reference

Advances and Challenges in Hemophilic Arthropathy

10.1053/j.seminhematol.2015.10.005 · 2016 · External reference

Defective TAFI Activation in Hemophilia A Mice Is a Major Contributor to Joint Bleeding

10.1182/blood-2018-01-828434 · 2018 · External reference

The Effects of GLP‐1 Agonists on Musculoskeletal Health and Orthopedic Care

10.1007/s12178-025-09978-3 · 2025 · External reference

GLP‐1 Receptor Agonists in Osteoarthritis and Psoriatic Disease: The Missing Link Between Obesity and Inflammation?

10.1007/s00296-026-06258-2 · 2026 · External reference

10.1136/rapm-2026-107658

10.1136/rapm-2026-107658 · External reference